新闻发布

19.09.2018 | Nanion Technologies and Ncardia Sign Co-Marketing and Support Agreement to enhance Options for Cardiac Researchers

MUNICH, Germany and COLOGNE, Germany, September 19, 2018-- Nanion Technologies GmbH, a leading provider of instrumentation for ion channel drug discovery and screening, and the Ncardia Group, a leading developer, manufacturer, and service provider of human induced pluripotent stem cells (iPSCs) for safety and efficacy testing announced today that they have entered into a joint marketing and sales promotion agreement.

Continue Reading

07.02.2018 | Søren Friis appointed Director of Global Customer Relations at Nanion

MUNICH, GERMANY February 7, 2018-- Nanion Technologies is pleased to announce that Søren Friis has been promoted to Director of Global Customer Relations at Nanion. Søren Friis was most recently Senior Application scientist at Nanion. He holds a very strong track record in developing advanced assays for automated patch clamp systems and for providing excellent support to customers world-wide in pharmaceutical companies and CROs.

Continue Reading

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.